Marinol (dronabinol) from Schedule II to Schedule III

The DEA is transferring Marinol (dronabinol) from Schedule II to Schedule III.

This will make it easier for patients to get synthetic THC for nausea and vomiting from chemotherapy...or for anorexia and weight loss associated with AIDS.

Marinol has a low abuse potential...probably due to its slow onset. It doesn't produce a quick "high" like marijuana.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote